NCT06587997

Unknown

Changes in Renal Perfusion During Hemodialysis in Patients w...

Yuanjun Yang Source

Other study identifiers

Sponsor study identifier

HD-RPC

Study Type

observational

Estimated enrollment

20

Locations

0 countries

Sites

N/A

Timeline

Study Start

September 5, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

September 3, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 3, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Residual renal function (RRF) characteristically declines after patients with end-stage renal disease (ESRD) initiate dialysis. Although RRF preservation correlates with improved patient\&#39;s quality of life and survival prospects, poor understanding of the pathophysiology underlying RRF decline limits protection strategies.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 20 participants
Study completion date: September 3, 2026
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
September 5, 2024
Actual (reported)
Study Start
September 5, 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
First Posted
September 19, 2024
Actual (reported)
Primary Completion
September 3, 2026
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 3, 2026
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: September 19, 2024
Status Verified: September 2024
Last Update Submitted: September 5, 2024

Conditions

End-stage Renal Disease

Keywords

hemodialysisrenal perfusionend-stage renal disease

Outcome Measures

Primary Outcomes (1)

renal perfusion
Changes in renal perfusion during hemodialysis in patients with end-stage renal disease
one day

Secondary Outcomes (3)

diastolic blood pressure
one day
systolic blood pressure
one day
urine volume
10 months

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

First Medical Center of Chinese PLA General Hospital

You may qualify if:

Age ≥ 18 years;

Sponsors & Collaborators

Yuanjun Yang
Otherlead

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Dayang Xie

CONTACT

13718941415 460436948@qq.com

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Target Duration: 10 Months
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Director

Study Record Dates

First Submitted

September 5, 2024

First Posted

September 19, 2024

Study Start

September 5, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

NCT06468826

A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

Phase 1Completed

NCT06479200

VR-Guided Mindfulness for ESKD Caregiver Well-Being

Not ApplicableUnknown

NCT06086470

Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease

Not ApplicableUnknown

NCT06625125

PMR vs MM for Patients on Hemodialysis

Not ApplicableNot Yet Recruiting

NCT06622200

The Effect of Mindfulness on Emotional Regulations Skills and Quality of Life Among Patients on Hemodialysis

Not ApplicableUnknown

NCT06389617

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

Not ApplicableUnknown

Clinical diagnosis of end-stage renal disease requiring long-term hemodialysis treatment, with dialysis duration ≤ 3 months;

Urine output \> 500ml/day or GFR \> 3ml/min/1.72m2;

Signed and dated informed consented is obtained.

You may not qualify if:

Presence of vascular access dysfunction (blood flow rate \< 180ml/min);
Severe heart failure;
Active infection;
Infectious disease;
Patients with severe anemia;
Patients with polycystic kidney disease;
Expected dialysis duration \< 6 months;
Pregnancy or lactation women;
Patients who are participating in other clinical studies, or who have participated in other clinical studies within 3 months prior to enrollment;
Unwillingness to be followed up or poor adherence to treatment;
Other circumstances that the investigator considers unsuitable for enrolment.

Contact the study team to confirm eligibility.

September 3, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 3, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

September 19, 2024

Record last verified: 2024-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT06587997
Data provider: ClinicalTrials.gov
Source updated: 2024-09-19
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:20 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record